ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EU Commission Grants New Indication for Soliris for Refractory gMG
August 23, 2017Alexion Pharmaceuticals announced the European Commission (EC) approved the extension of the indication for Soliris (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR -
Alexion moves to bolster patent protection of Soliris
August 18, 2017It’s no wonder that the company is stacking its patent defences against any potential biosimilar encroachment onto its sales territory in the short term future. -
Alexion wins 3 new Soliris patents as Amgen works on biosimilar of pricey drug
August 17, 2017Rare-disease drug Soliris is one of the most expensive drugs in the world, making it a prime target for biosimilars.
Pharma Sources Insight January 2025
